The trajectory of the erectile dysfunction drug presents a intricate picture for shareholders. While the initial launch generated substantial returns, the lapse of its exclusive rights opened the floodgates to generic https://isocialfans.com/story7226318/sildenafil-and-the-pharmaceutical-industry-a-volatile-investment